Dr. Roy Perlis on esketamine as an option for treatment-resistant depression.

madman

Super Moderator
To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Dr. Roy Perlis is the director of the Center for Quantitative Health at Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Kim and Others. Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class. N Engl J Med 2019;381:1-4.
 

Online statistics

Members online
2
Guests online
268
Total visitors
270

Latest posts

Back
Top